← All indications
Biomarkers, Tumor
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
Subtype terms (20)
More specific conditions that are subtypes of Biomarkers, Tumor in the MeSH hierarchy.
- alpha-Fetoproteins
3 drugs (2 approved, 1 experimental)
- Antigens, Tumor-Associated, Carbohydrate
- Carcinoembryonic Antigen
1 drug experimental
- Chorionic Gonadotropin, beta Subunit, Human
- Erb-b2 Receptor Tyrosine Kinases
13 drugs (11 approved, 2 experimental)
- Hormones, Ectopic
- Ki-1 Antigen
- Ki-67 Antigen
- Mammaglobin A
- Nephroblastoma Overexpressed Protein
- Neprilysin
- Normetanephrine
- Pancreatitis-Associated Proteins
- Proliferating Cell Nuclear Antigen
- Prostate-Specific Antigen
1 drug approved
- Receptor, ErbB-3
- Receptor, ErbB-4
- Synaptophysin
- Tissue Kallikreins
- Tissue Polypeptide Antigen
Drugs by status
Phase 2 trials (1)